Publications
Our mission is to improve the lives of individuals and families facing hereditary cancer.FORCE contributes to and collaborates with investigators who build on scientific knowledge through publication of research findings. Read the below list of publications and presentations that involved FORCE effort and staff.
Clark E; Bonini K; Pugh Yi R; Kuhn E; Klemp J; Rose D; Owens K N; Welcsh P; Conaty J; Duquette D; Friedman S J; Dean M. Patient Education and Counseling Volume 116, November 2023.
The National Academies Press. 2023.
People with metastatic breast cancer face barriers to finding information and support
Pugh Yi R; Welcsh P; Owens K; Rose D; Dearfield C; Kuhn E; Friedman S. Presented at the San Antonio Breast Cancer Symposium - December 9, 2022.
Lisa Schlager, Kelly Owens, PhD, Piri Welcsh, PhD, Presented at the International Society of Nurses in Genetics (ISONG) World Congress, November 2022.
Boninil K, Clark E, Pugh Yi R, Kuhn E, Klemp J, Rose D, Owens K, Welsh P, Duquette D, Friedman S, Dean M, presented at the NSGC conference, Nashville, 11/16/2022
Results of training on digital health literacy for genetic counseling training programs
Pugh Yi R, Dean M, Welcsh P, Owens K, Rose D, Dearfield C, Kuhn E, Clark E, Friedman S. Presented at the American Public Health Association annual meeting, November 6, 2022.
Caregiving in hereditary cancer: Caregivers’ resource and support needs
Mountcastle, L., Friedman, S., & Koehly, L.M. (2022, November 16-20). [Virtual Poster Presentation]. To be presented at the National Society of Genetic Counselors 41st Annual Conference, Nashville, TN.
Green, S., Hartzfeld, D., Terry, A. B., Fissell, K., Friedman, S., Paolino, N., Principe, K., Sandbach, J., Trzupek, K., Winheld, S., & Malinowski, J. (2022). Journal of Genetic Counseling. August, 2022.
Ganz P; Bandos H, Spanic T, Friedman S, Müller V; et. al. Cancer Res (2022) 82 (4_Supplement): GS4-09. February, 2022.
Medicaid expansions: Probing Medicaid’s filling of the cancer genetic testing and screening space
Modell, S.M.; Schlager, L.; Allen, C.G.; Marcus, G. Healthcare 2022, 10, 1066.
Using consistent terms in precision medicine to eliminate patient confusion
Martin N, Friedman S, Saxton C, Yarden R, Lindsey S, Kuhn E, Guglielmino J, et. al. Journal of Clinical Oncology 2020 38:15_suppl, e24164-e24164
Armstrong J, Lynch K, PhD2; Virgo K, Schwartz M, Friedman S, Dean M, Sutphen R, et. al. JCO Oncology Practice (ascopubs.org). JCO Oncology Practice 2021 17:2, e226-e235
BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study
Filipa Lynce, Ilana Schlam, Xue Geng, Beth N Peshkin, Sue Friedman, Julie Dutil, Claudine Isaacs, Kristi D Graves, et. al. J Genet Couns. 2021; 30: 383– 393.
The impact of germline testing for hereditary cancer postdiagnosis
Owens K, Schlager L, Welcsh PL. Am J Manag Care. 2019 Aug;25(9 Spec No.):SP285-SP287.
Yi, R. H. P., Rezende, L., Dearfield, C. T., Welcsh, P., & Friedman, S. (2019). Health Education Journal, 78(5), 607–617.
Pugh-Yi RH, Rezende, Dearfield CT, Owens KN, Welcsh PL, Friedman SJ. Dec. 8, 2018. San Antonio Breast Cancer Symposium Abstract P6-14-08.
Armstrong J, Toscano M, Kotchko N, Friedman S, Schwartz MD, Sutphen R. , et. al. JAMA Oncol. 2015 Dec;1(9):1251-60.
Pugh-Yi R, PhD, Rezende L, Kramer K, Schlager L, Huynh J, Friedman S. Presentation at the American Public Health Association National Meeting, November 2015.
Yi RHP, Rezende LF, Huynh J, Kramer K, Cranmer M, Schlager L, Dearfield CT, Friedman SJ. Health Commun. 2018 Dec;33(12):1525-1530. doi: 10.1080/10410236.2017.1372051. Epub 2017 Sep 28. PMID: 28956616.
Rezende L, Huynh J, Kramer K, Cranmer M, Schlager L, Pugh-Yi R, Friedman S. Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12.
Holman LL, Friedman S, Daniels MS, Sun CC, Lu KH. Gynecol Oncol. 2014 May;133(2):283-6. doi: 10.1016/j.ygyno.2014.02.030. Epub 2014 Feb 28. PMID: 24582866; PMCID: PMC4035022.